Capital raised by Montara Therapeutics
1 Form D filing · first filed Feb 2025 · San Francisco, CA
President & CEO
Signatory on Montara Therapeutics's Form D filings · $20.0M raised across 1
Nicholas Hertz is on file as President & CEO at Montara Therapeutics in San Francisco, CA. Montara Therapeutics has 1 Form D filing on record, $20.0M raised in total. Nicholas Hertz appears as a signatory on the company's filings.
The BrainOnly™ platform is Montara's core technology designed to facilitate brain-specific drug activity. It enables the development of therapies that selectively target neurological conditions while avoiding the toxicities typically associated with systemic treatments.
